Induction of ABCD2 is recognized as a therapeutic strategy for X-ALD.
The known inducers of ABCD2 and regulatory pathways are described.
LXR antagonists are novel inducers of ABCD2.
A few LXR antagonists that have been described are presented.
Their potential use for neurodegenerative disorders is discussed.